Stay updated with breaking news from 87837710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It […]
Zacks Investment Research downgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as […]
Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by stock analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a report issued on Monday, The Fly reports. They currently have a $370.00 price objective on the biotechnology company’s stock, down from their previous price objective of $400.00. Wells Fargo […]
Zacks Investment Research upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a report published on Wednesday, Zacks.com reports. Zacks Investment Research currently has $484.00 price objective on the biotechnology company’s stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and […]
StockNews.com started coverage on shares of Bio-Techne (NASDAQ:TECH – Get Rating) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s stock. A number of other brokerages have also commented on TECH. Zacks Investment Research upgraded shares of Bio-Techne from a sell rating to a hold rating in […]